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Abstract
Background: The gut is the most extensively studied niche of the human microbiome. The aim of this study was to
characterise the initial gut microbiota development of a cohort of breastfed infants (n = 192) from 1 to 24 weeks of age.
Methods: V4-V5 region 16S rRNA amplicon Illumina sequencing and, in parallel, bacteriological culture. The
metabolomic profile of infant urine at 4 weeks of age was also examined by LC-MS.
Results: Full-term (FT), spontaneous vaginally delivered (SVD) infants’ microbiota remained stable at both phylum and
genus levels during the 24-week period examined. FT Caesarean section (CS) infants displayed an increased faecal
abundance of Firmicutes (p < 0.01) and lower abundance of Actinobacteria (p < 0.001) after the first week of life
compared to FT-SVD infants. FT-CS infants gradually progressed to harbouring a microbiota closely resembling FT-SVD
(which remained stable) by week 8 of life, which was maintained at week 24. The gut microbiota of preterm (PT)
infants displayed a significantly greater abundance of Proteobacteria compared to FT infants (p < 0.001) at week 1.
Metabolomic analysis of urine at week 4 indicated PT-CS infants have a functionally different metabolite profile than FT
(both CS and SVD) infants. Co-inertia analysis showed co-variation between the urine metabolome and the faecal
microbiota of the infants. Tryptophan and tyrosine metabolic pathways, as well as fatty acid and bile acid metabolism,
were found to be affected by delivery mode and gestational age.
Conclusions: These findings confirm that mode of delivery and gestational age both have significant effects on early
neonatal microbiota composition. There is also a significant difference between the metabolite profile of FT and PT infants.
Prolonged breastfeeding was shown to have a significant effect on the microbiota composition of FT-CS infants at 24 weeks
of age, but interestingly not on that of FT-SVD infants. Twins had more similar microbiota to one another than between two
random infants, reflecting the influence of similarities in both host genetics and the environment on the microbiota.
Background
The gut microbiota is increasingly regarded as an ‘invis-
ible organ’ of the human body and considered an im-
portant factor for host health. This dynamic microbial
population develops rapidly from birth until 2 to 3 years
of age, when adult-like composition and stability is
established [1, 2]. If the establishment of the stable adult
microbiota is programmed in infancy, it may lead to a
lifelong signature with significant effects on health.
Bacterial colonisation begins at birth, although recent
papers have suggested microbiota acquisition occurs in
utero [3], challenging the traditional dogma of uterine
sterility. The developing gut microbiota of neonates dif-
fers widely between individuals [2] and both internal
host properties and external factors influence the estab-
lishment of the microbiota [4]. At birth, the infant mi-
crobial population resembles the maternal vagina or skin
microbiota depending on mode of delivery, i.e. by spon-
taneous vaginal delivery (SVD) or Caesarean section
(CS), respectively [5]. Birth mode has a significant effect
on the nascent neonatal gut microbiota after these initial
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founder populations have been replaced [6–9]. At 1 week
of age, the microbiota of the SVD infant gut is charac-
terised by high levels of Bifidobacterium and Bacteroides,
while Clostridium is more abundant in CS neonates [10].
Numerous other factors have been shown to exert an
influence on this development, including antibiotic ex-
posure [11] and breastfeeding [12, 13]. Development of
the microbiota occurs as bacteria are replaced in a dy-
namic, non-random pattern [14, 15]. The use of infant
milk formula (IMF) impacts on metabolism [16] and
development of the neonatal immune system [17]. This
introduction of IMF or solid food perturbs bacterial
colonisation [18, 19] and may reduce the benefits of ex-
clusive breastfeeding [17].
Preterm (PT) neonates experience a number of unique
challenges to the establishment of their microbiota. CS
delivery, maternal and neonatal exposure to antibiotics
and the sterile environment of the neonatal intensive
care unit (NICU) may all alter the natural pattern of ac-
quisition of microbiota. A few published studies with
high subject numbers examining the PT gut microbiota
mainly focus on the initial hospitalised period [15, 20]. A
knowledge gap surrounding PT gut microbiota develop-
ment was recently highlighted [21], and to our know-
ledge, the current study is the largest, well-phenotyped
analysis of the longitudinal microbiota development of
PT infants after leaving the hospital environment. It has
previously been suggested that post-conceptional age, ra-
ther than post-birth age, is the main determinant of the
bacterial community profile in preterm infants [15]; the
aforementioned factors were found to influence the
pace, but not the sequence, of microbial acquisition.
Metabolites have been shown to influence regulatory T
cells in the gut [22], with changes posited to contribute to
autoimmune diseases including inflammatory bowel disease,
asthma, allergies, arthritis and multiple sclerosis [23, 24].
These conditions have also been linked to CS and PT birth.
In this prospective study, we compared the gut micro-
biota of initially breastfed infants from a single geo-
graphical area (Cork, Ireland) who were born under
different birth modes (SVD or CS) and different gesta-
tional ages (FT or PT), in the same maternity hospital.
We investigated the effect of both of these factors on
the establishment of the nascent gut microbiota of
breast fed infants. We also examined the link between
the microbiota and the metabolome in early life through
comparison of urine metabolomic data with 16S gut
microbiota data.
Methods
Participants and sample collection
The infants included in this study are part of the
INFANTMET study cohort. Mothers were approached
for consent between February 2012 and May 2014 at the
Cork University Maternity Hospital, with ethical ap-
proval provided by the Cork University Hospital Re-
search Ethics Committee (ethical approval reference:
ECM (w) 07/02/2012). The study design was to recruit
groups of infants according to birth mode and gestation:
FT-SVD, FT-CS, PT-SVD and PT-CS infants (PT; less
than 35 weeks gestation). Information about the in-
fants was collected at delivery using medical records.
Further data were collected using detailed question-
naires given to the mothers when the infants were
1 year old (Additional file 1: Table S1). Faecal samples
were collected from the infants at 1, 4, 8 and
24 weeks of age (Table 1). PT infants were sampled
at 1 week of age and the same time points (i.e. weeks
4, 8 and 24) after the due delivery date. Samples were
collected and placed at 4 °C by the mother, before
collection in a temperature-controlled transport col-
lection case by the research nurse for transport to the
lab for DNA extraction. An additional sample was ac-
quired at the due date of delivery for PT infants.
Urine samples were also collected at 4 weeks of age
for metabolomic analysis using Sterisets Uricol Urine
Collection Pack (Medguard, Ireland). A pad was placed
in the diaper and used to collect an unsoiled urine sam-
ple from the infant. The pad was then placed in a bio-
hazard bag and frozen immediately by the mothers. This
frozen sample was collected in conjunction with the
week 4 faecal sample and placed in a −80 °C freezer
upon arrival at the lab prior to processing.
The PT infants in the study had a mean gestational
age of 31 weeks and 6 days (SD ± 2 weeks 5 days) and
mean birth weight of 1715 g (SD ± 564 g). Twenty six
of the PT infants were born between 32 and 35 weeks,
while the remaining infants were less than 32 weeks
gestation (range 24–32 weeks). There were 10 multiple
births (9 twin and 1 triplet set) and 20 singleton births;
two thirds were male and one third was female. All but
four PT infants were born by CS (emergency 73% and
elective 12%). The average length of stay in the neo-
natal unit was 39 days (SD ± 39.14, range 4–190 days).
All infants under 32 weeks gestation received one
course of antibiotics, with a third receiving at least one
additional course. In comparison, only one third of
Table 1 Breakdown of total number of faecal samples collected
in the study
FT-CS PT-CS FT-SVD PT-SVD Total
Week 1 70 35 83 4 192
Week 4 56 30 63 3 152
Week 8 62 27 74 4 167
Week 24 62 30 74 4 170
Due date N/A 30 N/A 4 34
Total 250 152 294 19 715
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infants born between 32 and 35 weeks gestation re-
ceived a course of antibiotics and only 4% received a
second course. See Additional file 1: Table S2 for fur-
ther details on PT infants.
Sample extraction and processing
Faecal samples were processed within 24 h of collection
after storage at 4 °C, without freezing. Microbial DNA
was extracted from 0.2-g stool samples using the repeat
bead beating (RBB) method described by Yu and Morri-
son [25], with some modifications. A 0.2-g stool sample
was incubated with 1 ml RBB lysis buffer (500 mM
NaCl, 50 mM tris-HCL, pH 8.0, 50 mM EDTA and 4%
sodium dodecyl sulphate (SDS)) in a 2-ml screw cap
tube with 0.5 g sterile zirconia beads (A single 3.0 mm
bead, 0.1 g of 0.5 mm beads and 0.3 g of 0.1 mm beads).
It was homogenised for 90 s (Mini-Beadbeater™, BioSpec
Products, Bartlesville, OK, USA), with the tubes cooled
on ice for 60 s before another 90 s of homogenisation.
Samples were incubated at 70 °C for 15 min to further
lyse the cells. Samples were centrifuged (16,000g), the
supernatant was removed, and the RBB steps were re-
peated with 0.3 ml of RBB lysis buffer. The supernatants
were pooled and incubated with 350 ml of 7.5 M ammo-
nium acetate (SIGMA). The DNA was precipitated by
isopropanol, centrifuged at 16,000g into a nuclear pellet
which was washed with 70% (v/v) ethanol. The pellet
was allowed to dry, then re-suspended in TE buffer, and
treated with RNAse and Proteinase K. It was cleaned
with QIAGEN buffers AW1 and AW2 using a QIAGEN
column and eluted in 200 μl of AE buffer (QIAamp
DNA Stool Mini Kit, QIAGEN, UK). DNA was visua-
lised on a 0.8% agarose gel and quantified using the
Nanodrop 1000 (Thermo Scientific, Ireland). DNA was
then stored at −80 °C.
Primers used for PCR amplification were the V4–V5
region primers 520F (AYTGGGYDTAAAGNG) and
926R (CCGTCAATTYYTTTRAGTTT) (Additional file 1:
Table S3). Initial primers for Illumina sequencing contain
the sequencing primer binding sites, forward or reverse
16S rRNA gene specific primer and a 10nt in-line multi-
plexing identifier (MID). Dual separate MIDs were at-
tached to both ends of the PCR product (Additional file 1:
Table S3).
The V4–V5 amplicons for Illumina sequencing were
generated using a two-step amplification procedure. The
first step reaction mix contained 50 μl BIO-X-ACT™
Short Mix (BIOLINE), 10 μl of 2 nM forward and re-
verse primers, 50 ng genomic DNA and ddH20 to give a
final volume of 100 μl. Cycling conditions were the fol-
lowing: an initial 95 °C, 5-min denaturation step; 30 cy-
cles of 95 °C for 15 s, 42 °C for 15 s and 72 °C for 30 s;
and a final 10-min extension at 72 °C. The products
were purified using SPRIselect beads (Beckman Coulter,
Indianapolis, IN) as per manufacturer’s instructions,
using a 0.9:1 volume ratio of beads to product. The puri-
fied PCR products were eluted in 40 μl of ddH2O. DNA
quantity was assessed via Quant-iT™ PicoGreen® dsDNA
Assay Kit (Invitrogen™). The samples were pooled in
equimolar amounts (20 ng DNA per sample) and se-
quenced at the University of Exeter (UK) using Illumina
MiSeq 2 × 300 bp paired-end sequencing, on multiple
sequencing runs. Nextflex Rapid library preparation was
carried out by the sequencing laboratory to attach bridge
adaptors necessary for clustering.
LC-MS metabolomic analysis of urine
Urine samples were extracted as previously described
[26]. A 100-μl urine sample was placed on a 96-well
plate with PVDF filter 0.45 μm, together with 200 μl of
internal standard in methanol (see Additional file 2:
Supplementary materials for details). Samples were
then filtered using a positive pressure-96 manifold
(Waters, USA). The eluate was diluted with 200 μl of
MiliQ water containing cinnamic acid standard.
Untargeted LC-MS assays were performed with a hy-
brid linear ion trap Fourier Transform (LTQ FT)
Orbitrap mass spectrometer (Thermo Fisher, Bremen,
Germany), in positive and negative ionisation modes.
The XCMS Online portal (https://xcmsonline.scripp-
s.edu/) was used for data processing (alignment, peak
picking, zero peak re-integrations, features grouping
and assessment of quality control samples); please see
Additional file 2: Supplementary materials for details.
Data obtained from this processing consisted of a list
of m/z features and its relative intensities, which vary
between sample groups. Such matrix file, with infor-
mation about sample codes, m/z feature and its in-
tensity, was used for statistical analysis. In positive
ionisation mode, 2380 statistically significant features
were found. In negative ionisation mode, there were
3832 statistically significant features. To annotate
compounds, a selection strategy was used based on
the most abundant and the most statistically signifi-
cant features. The procedure for annotation of com-
pounds was adapted from standard metabolomic
initiatives (see Additional file 2: Supplementary mate-
rials for details). Levels of identification were as fol-
lows: level I corresponds to compounds identified by
matching masses and retention times with authentic
standards in the laboratory, or by matching with
high-resolution LC-MS and LCMSn spectra of stan-
dards reported in the literature; and level II corre-
sponds to compounds identified by matching with
high- and low-resolution LC-MS and LC-MSn spectra
from databases and literature. Compounds identified
only by spectral similarities to a similar compound
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class and literature knowledge are reported as level
III. Unknown compounds are reported as level IV.
Bioinformatic analysis
The Illumina MiSeq 2 × 300 bp paired-end sequencing
reads were joined using the Fast Length Adjustment of
SHort reads to improve genome assemblies (FLASH)
programme [27]. MIDs were extracted and sequences
were assigned to their corresponding individual samples
by QIIME’s split_libraries_fastq.py, permitting two am-
biguous bases per MID (Ns), and using QIIME’s default
quality settings. The USEARCH sequence analysis tool
[28] was used for further quality filtering. Sequences
were filtered by length, retaining sequences with lengths
of 350–370 bp. This range was used to select the most
abundant sequences for the base of each operational
taxonomic unit (OTU) with reads of all lengths then
aligned to the OTU sequences. Single unique reads were
removed, and the remaining reads were clustered into
OTUs. Chimaeras were removed with UCHIME, using
the GOLD reference database. The original input se-
quences were mapped onto the OTUs with 97% simi-
larity. All reads were taxonomically classified by the
classify.seqs command within the mothur suite of tools
(v1.31.2), using the RDP reference database (training
set 14) [29]. OTUs were classified from these when
>50% of the reads agreed on a classification at each
phylogenetic level. The returned read numbers varied
greatly from 129 to 815,400 reads (average = 69,410
reads per sample). To adjust for the influence of the
number of sequences in a sample on diversity and other
statistical tests, any sample with less than 10,000 se-
quence reads was eliminated from the study. This re-
sulted in the loss of eight samples from the data set.
Fifteen samples had been sequenced in duplicate, so the
samples with the lower read numbers of duplicated
pairs were removed, as we believed that these may not
be the best representations of those samples due to the
lower read counts. The OTU table containing the
remaining 715 samples was rarefied to 10,000 reads, to
remove any bias from variation in sample read num-
bers. The remaining samples were from variable modes
of delivery and time points (data not shown).
Culture-dependent analysis
One gramme of fresh faecal sample per infant was serially
diluted in maximum recovery diluent (Fluka, Sigma
Aldrich, Ireland). Enumeration of bifidobacteria was per-
formed by spread-plating serial dilutions onto de Man,
Rogosa, Sharpe agar (Difco, Becton-Dickinson Ltd.,
Ireland) supplemented with 0.05% L-cysteine hydrochlor-
ide (Sigma Aldrich), 100 μg/ml mupirocin (Oxoid, Fannin,
Ireland ) and 50 units nystatin suspension (Sigma
Aldrich). Agar plates were incubated anaerobically at 37 °C
for 72 h (Anaerocult A gas packs, Merck, Ocon Chemicals,
Ireland). Enumeration of lactobacilli was determined by
plating samples onto Lactobacillus selective agar (Difco)
with 50 units nystatin and incubated anaerobically at 37 °C
for 5 days. Bacterial counts were recorded as colony form-
ing units (CFU) per gram of faeces and were log10 trans-
formed prior to statistical analyses.
Statistical analysis
Statistical analysis was performed using the R statistical
framework, using a number of software packages or li-
braries including, made4, vegan, DESeq2, car, nlme and
lme4. Relative abundance bar charts were generated with
Microsoft Excel. Where possible, statistical analyses of
changes over time take the subject numbers into ac-
count, such as the alpha diversity linear modelling, and
DESeq2 tests for differential abundance.
To assess alpha diversity, we calculated the Shannon
Diversity Index with the diversity function from the R
vegan package. After fitting Shannon Diversity to mul-
tiple distributions and performing Shapiro-Wilk normal-
ity tests, we found that it best approximated a normal
distribution, as determined by Quantile-Quantile plots
(qqplots; not shown). Therefore, differences of alpha di-
versity between infants of different modes of delivery at
a given time were detected using mixed effect linear
models (R package nlme), which allow for the adjust-
ment of sequencing run (random effect), while testing
for differences due to mode of delivery (mixed effect). In
order to compare alpha diversity over time, mixed effect
linear models were applied (R package lme4, and Ana-
lysis of Deviance using the ANOVA command from the
Car package to test for significance), which allow for
controlling for the subjects and the age of the infants,
along with sequencing run.
Multiple beta diversity metrics were also calculated, in-
cluding weighted and unweighted UniFrac and Spearman
distance ((1 – Spearman Correlation)/2). Principal coordi-
nates analysis was performed on each beta diversity metric
to highlight the separation of infants based on mode of
delivery and sampling time point. Differences between
groups were tested for using permutational multivariate
analysis of variance (PerMANOVA) on beta diversity
matrices, adjusting for sequencing run. False discovery
rate was adjusted for with Benjamini-Hochberg [30].
To identify taxa (phyla and genera) that may be driv-
ing the significant differences detected between time
points and mode of delivery, differential abundance ana-
lysis was determined using DESeq2 on raw phylum- and
genus-level count data. We determined that DESeq2 was
an appropriate tool for differential abundance analysis as
the negative binomial model best fit all genera, deter-
mined by the “goodfit” command from the “vcd” R pack-
age. A heatplot was generated to highlight the major
Hill et al. Microbiome  (2017) 5:4 Page 4 of 18
genera driving clustering of samples from different modes
of delivery at different time points and to identify bacterial
co-abundance. We used only genera that were found in at
least 10% of the samples, and utilised Spearman correl-
ation and Ward clustering on log10 of the rarefied genus
count matrix.
We determined significant differences of culture-
dependent count data between time points or mode of
delivery using the Wilcoxon rank sum test, and adjusted
for false discovery rate with Benjamini-Hochberg. Corre-
lations between culture-dependent (plate count) and
culture-independent (16S sequencing) data were deter-
mined using Pearson’s product-moment correlation.
Pearson’s product-moment correlation was also used to
determine if abundance of any genera correlated with
that of any other genera, and the false discovery rate was
adjusted with Benjamini-Hochberg. To determine if
twins were more closely related to each other than ran-
dom infants, we performed t tests with Monte-Carlo
simulations on beta diversity between samples.
The urine metabolomics dataset was unit scaled before
significant features were identified using the ANOVA
statistical test with term and delivery mode as explana-
tory variables. This analysis gave consistent results when
compared to pareto scaled data and ANCOVA as the
statistical test with 84% of the identified metabolites be-
ing returned (data not shown). The logged fold change
and the mean value for each variable were calculated
and the results were filtered using the false discovery
rate (FDR) calculated from the raw p values. To aid the
identification of metabolites, an additional clustering
analysis was performed by WGCNA cluster analysis
using the Spearman correlation and a soft threshold of
nine [31].
Results
Drivers of infant gut microbiota
Gut microbiota is influenced by mode of delivery and
gestational age
The structure of the infant gut microbiota is clearly af-
fected by mode of delivery (Fig. 1, Additional file 1:
Table S4). The results demonstrate that there was a sig-
nificant difference in microbiota composition at genus
level across the four different groups from week 1 to
week 24, when analysed by Spearman distance matrix
and visualised by principal coordinates analysis (PcoA).
At 1 week of age, the microbiota composition of the
FT-CS group was significantly different from that of
both PT-CS and FT-SVD groups (p values <0.001).
PT-CS and FT-SVD were also distinct from one an-
other (p < 0.001). The low number of PT-SVD infants
(n = 4) did not permit significant testing at this time
point, but it is worth noting that this microbiota clus-
ter is situated between the PT-CS and FT-SVD
groups. At 4 weeks of age, FT-CS microbiota was sig-
nificantly different to all other groups (p < 0.001). The
PT infant microbiota mainly separated across the x-
axis. At 8 weeks of age, the FT-CS group is distinct
from both PT-CS and FT-SVD (p < 0.001), separated
on both axes. The FT-SVD and PT-CS are also dis-
tinct (p < 0.001); all three groups have significantly
different microbiota composition at 8 weeks of age.
By 24 weeks, there were no significant differences between
PT-CS and FT-CS microbiota, while FT-CS and FT-SVD
microbiota were still significantly different (p < 0.01). At
this time point, mode of delivery remains influential while
differences due to gestational age have been elimi-
nated. At all time points, there was wide diversity of
individual population structures within each group,
showing the heterogeneous composition of the devel-
oping infant gut microbiota.
Distinctive metabolomic profiles are associated with
microbiota profiles
Co-inertia analysis of the week 4 microbiota data at the
OTU level and the metabolomic dataset showed that
there was a significant (p < 0.05) amount of co-variation
in the two datasets (Fig. 2). There was little separation
observed between FT birth modes (FT-CS and FT-SVD);
however, the PT-CS samples separated distinctly from
the FT samples. The co-inertia analysis showed that
there were greater differences between the group micro-
biota profiles than between the group metabolomic pro-
files. These differences are evident where the FT
metabolomic baricentres are overlaid while there is a
separation between the microbiota baricentres. The PT-
SVD metabolomic and microbiota baricentres were rela-
tively distant from one another, but this separation may
be due to the low number of samples in each of these
groups. The compounds associated with the PT-FT split
are from multiple different sources and were represented
by a diverse selection of metabolites (Additional file 3:
Figure S1, Additional file 1: Table S5). Annotated metab-
olites were grouped based on their origin and chemical
character: (i) amino acids and metabolites; (ii) carboxylic
acids and phenolic acids and their metabolites; (iii) vita-
mins and their metabolites; (iv) drugs and their me-
tabolites; (v) carnitines; (vi) indole metabolites; and
(vii) fatty acids and their metabolites (see Additional
file 1: Tables S5 and S6). Urea and its associated me-
tabolite derivatives were situated in the centre of the
metabolite cluster, suggesting it is abundant in both
groups, providing confidence in our classifications.
We found a number of paracetamol metabolites to be
significantly higher in PT infants, as well as several dif-
ferent vitamins and their metabolites such as riboflavin,
CECH—a tocopherol metabolite or pyridoxic acid
(Additional file 1: Table S5). These metabolites may be
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due to altered medical treatment of PT infants. Among
endogenous metabolites found to be statistically signifi-
cant, two families could be easily identified: tryptophan
and tyrosine. Metabolites belonging to tryptophan path-
way were kynurenine, indoxyl sulphate, indole acetic acid,
while those belonging to tyrosine were acetylphenylala-
nine, acetyl tyrosine and hydroxyphenylalanine sulphate.
The accurate mass and fragmentation pattern of a
number of features that were elevated in the urine of the
PT group were consistent with bile acids; all of them
conjugated to glycine. We found glycocholic acid, one
sulphate conjugate of chenodeoxyglycocholic acid (or its
isomer glycoursodeoxycholic acid) and three atypical bile
acids (Additional file 1: Table S5).
Among small carboxylic acids we found succinic acid
and its derivatives are statistically lower in PT, while several
metabolites of glutamic acid were found at higher levels.
Finally, a number of fatty acids were found to be sta-
tistically higher in PT-CS infants. Most of them were
found as dicarboxylic species, with different hydroxyl-
ation patterns and with different saturation levels; more-
over, some were found as glucuronide conjugates.
Fig. 1 Birth mode and gestation age both significantly affect the composition of the infant gut microbiota to 24 weeks of age. Principal coordinates
analysis (PCoAs) on Spearman distance matrices of samples at each of four time points (weeks 1, 4, 8 and 24) revealed significant differences between
the groups. Significance was calculated using permutational multivariate analysis of variance (PerMANOVA, Additional file 1: Table S3). *p < 0.05;
**p < 0.01; ***p < 0.001
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Differentially abundant taxa drive microbiota clustering
over time
The abundance of genera can also be represented by a
heat plot of hierarchically clustered samples (Fig. 3),
which helps classify differentially abundant taxa. Many
of the samples cluster by time point, where week 1 and
week 24 in particular show relatively tight clusters.
Weeks 4 and 8 show some variation, which is possibly
due to the inclusion of FT and PT infants, whereas PT
infants are slightly older, due to the time point of sam-
pling. Very few genera are present at high abundance at
week 1, as bacterial diversity is lowest at this time point.
The genera that are abundant at week 1 decrease in rela-
tive abundance by week 24 (branch 1), as other genera
begin to emerge at detectable levels as the infants age
(branch 2). This trend is visible through week 8, when
another cluster of genera begins to emerge (branch 3).
By week 24, the genera that were most abundant at week
1 have markedly reduced in proportion (branch 1). Gen-
era on branch 2 have low relative abundances, whereas
genera on branch 3 are found to be quite highly
abundant. Within this third branch we find genera that
are core to enterotypes, such as Prevotella, Blautia and
Ruminococcus. Once Bifidobacterium emerged (at week
1 for some samples, and by week 4 for others), their
abundances appear to remain relatively stable, at least to
24 weeks of age.
Breastfeeding influences the gut microbiota of CS infants
We collected categorical metadata on how long each
infant was breastfed. Three categories were recorded:
between 1 and 2 months, between 2 and 4 months,
and greater than 4 months. We used PerMANOVA
to compare the microbiota of infants in these categor-
ies, and also examined the birth mode effect separ-
ately (Additional file 1: Table S7). No differences were
detected between the microbiota composition of in-
fants who were breastfed for 1 to 2 months and those
breastfed for 2 to 4 months. However, comparing in-
fants breastfed for less than 4 months and those for
longer than 4 months revealed a significant difference
for FT-CS but not FT-SVD (Fig. 4). Five genera were
Fig. 2 Co-inertia analysis of urine-derived metabolomic and 16S rRNA gut microbiota data from stool. Microbiota data was scalar normalised and
logged. Microbiota is represented by circles and the metabolomic samples are represented by squares. Four groups are visualised; preterm-Caesarean
section (blue), preterm-spontaneous vaginal delivery (orange), full-term Caesarean section (red) and full-term spontaneous vaginal delivery (green). Small
objects represent the individual samples and large objects represent the barycentre of the group. Analysis shows that the co-variance between the
microbiota and metabolomics dataset splits the preterm infants from the full-terms. Metabolites associated with this split are highlighted in Additional
file 3: Figure S1 and Additional file 1: Table S4
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significantly more abundant in infants that were
breastfed for longer and four genera were more abun-
dant in infants that were breastfed for a shorter duration
(Additional file 1: Table S8). Bifidobacterium was not
found to significantly differ in abundance based on dur-
ation of breastfeeding (also tested with Wilcoxon Rank
Sum test; data not shown).
Twins have more similar gut microbiota than unrelated infants
There were ten sets of twins and one set of triplets within
the cohort. Twenty one of these 23 infants were in the
PT-CS category; we therefore focussed only on these in-
fants. Using t tests with Monte-Carlo permutations, we
determined that at week 1, twins’ microbiota were more
similar within twin pairs than between non-twin pairs
(Spearman distance test: p < 0.001). This is also true
at weeks 4, 8 and 24 (p < 0.001 at each time point)
(Additional file 4: Figure S2).
Gut microbiota of preterm infants is influenced by post-birth
age
For the week 1 time point, all infants were approxi-
mately 1 week post-birth (range 6 to 8 days). However,
at other time points, PT infants were chronologically
older than FT infants, as the samples for these time
points were collected at weeks post due date rather than
post-birth. This was to ensure all infants were the same
post-conceptional age when sampled, as this was previ-
ously postulated to have the greatest effect on the estab-
lishment of the microbiota [15]. Infants were assigned to
groups depending on how many weeks premature they
were at birth (4, 5, 6, 7, 8, 9 or 12 weeks). We found that
at 1 week of age, when all PT infants are the same post-
birth age, no significant difference or trends were appar-
ent. At predicted due dates, three comparisons showed
significant differences, with a further seven showing a
trend for differences (Additional file 1: Table S9).
Fig. 3 Infants separate temporally and into three distinct clusters based on differentially abundant taxa. The three clusters may indicate the
beginning of an enterotype-based microbiota profile as early as 24 weeks of age. Only those genera (side) that are present in at least 10% of
samples (top) are shown. Samples are highlighted by the time point at which they were obtained
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Description of the infant gut microbiota
Differential abundance at phylum and genus level in infant
groups
We utilised DESeq2 in order to identify bacteria respon-
sible for the microbiota separation of the different
groups at phylum and genus levels. The main differences
are outlined below, with a full list of all differentially
abundant genera available in Additional file 1: Tables
S10–S17).
Phylum level
Using relative abundance of phyla from the rarefied
dataset, we determined the major bacterial phyla in the
different infant groups (Fig. 5). A clear distinction is ap-
parent between the different infant groups at 1 week of
age. The FT-SVD infants have a relatively consistent
microbiota composition from 1 to 24 weeks of age. The
dominant phylum throughout this period is the Actino-
bacteria (mainly comprised of the genus Bifidobacter-
ium). FT-CS infants initially had a higher relative
proportion of Firmicutes at 1 week of age compared to
FT-SVD (p < 0.05) and less Actinobacteria (p < 0.001). At
4 weeks of age, Actinobacteria (p < 0.01) and Bacteroi-
detes (p < 0.001) were more abundant in FT-SVD in-
fants, again with Firmicutes less abundant (p < 0.01).
Within the FT-CS group, Actinobacteria significantly in-
creased in relative abundance from 1 to 4 weeks of age
(p < 0.001). Bacteroidetes increased significantly in pro-
portion from week 4 to week 8 (p < 0.05) and again from
week 8 to week 24 (p < 0.001). Thus, the FT-CS micro-
biota progressed over time to one which is similar to the
FT-SVD infants with no differences at phylum level at
either 8 weeks or 24 weeks of age.
The most pronounced difference between the FT-CS
infant gut and the PT-CS gut is evident at 1 week of age
when there is a significantly higher proportion of Pro-
teobacteria in PT infants (p < 0.001). The PT-CS group
also harbours an initially high relative proportion of Fir-
micutes at week 1 before becoming dominated by both
Actinobacteria and Firmicutes from weeks 4 to 24.
Genus level
The infant gut is dynamic and a number of genera dem-
onstrate significant abundance differences between
groups (Fig. 6 and Additional file 1: Table S10–S13) and
within groups at different ages (Additional file 1: Table
S14–S17). We identified genera which were differentially
abundant in at least two of the groups and thus found
21 genera that had dissimilar abundances at week 1, 41
genera at week 4, 39 genera at week 8 and 25 genera at
week 24 (Additional file 1: Tables S10–S13). Some of the
significant changes are described below.
As expected, Bifidobacterium were found to be a
major component of the infant gut. Bacteroides and
Clostridia were also important contributors to the gut
microbiota composition. Despite the apparently large
difference in the average proportion of Bifidobacterium
at week 1 between FT-CS and FT-SVD (19 vs 48%), this
difference is not statistically significant, due to the high
inter-individual variation between infants at this early
age. There was no statistically significant difference in
the relative proportion of Bifidobacterium between these
two birth modes at any time point. Bacteroides was
found to be significantly more abundant in FT-SVD in-
fants compared to FT-CS at both 1 and 4 weeks of age
(p < 0.001), but not at later time points. Parabacteroides
Fig. 4 Breastfeeding duration influences the gut microbiota of C-section infants but not naturally delivered infants at 24 weeks of age. a Caesarean
section, full-term infants. b Naturally delivered full-term infants. In blue are infants that were breastfed for less than 4 months (i.e. between 1
and 2 months, or between 2 and 4 months). In red are infants that were breastfed for longer than 4 months. The vast majority of infants in
the cohort were breastfed for 1 month
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Fig. 6 Comparison of the microbiota composition of infants born by different birth modes and gestation duration at the same age across four
time points from 1 week to 24 weeks of age. The most pronounced differences are evident at week 1 of age, with the microbiota composition
becoming increasingly uniform over time to 24 weeks. Showing genera found at >1% average in total population. Genera found at <1% were
grouped as ‘other’
Fig. 5 Naturally delivered infant microbiota remains stable at phylum level from 1 to 24 weeks of age, while C-section delivered infants progress
to a similar microbiota profile over time. There is no shift in the FT-SVD infant composition from 1 to 24 weeks of age. FT-CS progresses by in-
creasing the relative abundance of Actinobacteria (p < 0.001) and Bacteroidetes (p < 0.001) and decreasing the relative abundance of Firmicutes
(p < 0.05) over the same period. PT-CS infants initially have a higher abundance of Proteobacteria compared to the FT groups (p < 0.001). Between
week 1 and week 4 the Proteobacteria and Firmicutes abundance decreased (p < 0.001 and p < 0.01, respectively). No significant differences were
recorded after week 4. The PT-SVD group had low subject numbers (n = 4), hindering significant associations, resulting in no significant changes
being observed. Showing phyla found at >1% average in total population. Phyla found at <1% were grouped as ‘other’
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were also significantly more abundant at 4 weeks of age
in FT-SVD than FT-CS (p < 0.001). We also observed
that PT-CS had a higher relative proportion of Bacter-
oides at 4 weeks of age compared to FT-CS. Clostridium
sensu stricto is significantly more abundant in FT-CS
when compared to FT-SVD at week 1 (p < 0.001). At this
time point, it is also more abundant in PT-CS than PT-
SVD (p < 0.01) but, as for Bacteroides, no differences
were observed at the later time points.
We noted very little development of the FT-SVD
microbiota composition at genus level throughout the
24 week period studied (Fig. 6, Additional file 1: Table
S16). From week 1 to 4 to 8, no genus was found to be
significantly altered in relative proportion. From week 8
to week 24, only Blautia (p < 0.05), and Subdoligranulum
(p < 0.01; representing a very low proportion of the over-
all microbiota composition) were found to significantly
change in abundance. Contrastingly, there were 12 and
16 genera that showed significantly altered relative pro-
portions between week 1 and week 4 for FT-CS
(Additional file 1: Table S14) and PT-CS (Additional
file 1: Table S15) respectively, indicating a high level
of microbiota change in the early life of these infants.
Sampling of subsequent time points does not demon-
strate this level of compositional change indicating a sta-
bilisation of the infant gut microbiota. The statistical
analysis of PT-SVD gut microbiota development was hin-
dered by low subject numbers, but notwithstanding this
limitation, we observed a number of significant changes
between week 8 and week 24, with relatively few changes
at earlier time points (Additional file 1: Table S17).
Co-abundance analysis is a useful way to reveal higher-
level constraints and associations in microbiota compos-
ition [32]. We therefore examined the relationship between
abundances of genera. Given that many genera appeared or
increased in abundance over the time period assessed
within this study we expected numerous positive correla-
tions. We therefore tested whether any genera were nega-
tively correlated. Of 12,090 correlations tested, after
adjusting for multiple testing, 16 were significant negative
correlations (Additional file 1: Table S18). Fourteen of these
significant negative correlations involved Bifidobacterium.
Diversity of the gut microbiota increases with age
Alpha diversity is a measure of the overall diversity of
the community present in a sample. The alpha diversity
of the infant gut microbiota was shown to be influenced
by age and birth mode (Fig. 7). As measured by the
Shannon index, α-diversity increases as the infant ages.
However, the microbiota diversity in each group did not
increase equally over the first 24 weeks of life (Fig. 7,
Additional file 5: Figure S3). We observed that the
groups have a different diversity relative to each other at
week 24 when compared to week 1. At 1 week of age,
the FT-SVD microbiota displays the highest diversity
of all groups, while PT-SVD is lowest. Diversity of all
four groups increases from week 1 to week 4. FT-
SVD increases in diversity between 1 and 4 weeks of
age (p < 0.001); then diversity reduces slightly between
week 4 and week 8 (p < 0.001); before increasing again
between week 8 and 24 (p < 0.001). PT-CS diversity in-
creased from weeks 1 to 4 (p < 0.001); 4 to 8 (p < 0.001);
and showed a trend toward an increase from week 8 to 24
(p < 0.1). FT-CS increased from weeks 1 to 4 (p < 0.001)
and weeks 8 to 24 (p < 0.01) but not between weeks 4 and
8. The overall increase in bacterial diversity is comparable
in both FT groups. PT-SVD infants microbial diversity in-
creased between week 1 and 4 (p < 0.001) and then ap-
pears to stabilise, with no further significant increase at
24 weeks. By week 24, there are no significant differences
in alpha diversity between any groups, but a trend can be
observed for higher diversity in FT-CS over PT-SVD, sug-
gesting that infants of different birth modes and term have
reached an equivalent diversity state at this age.
Correlation of bacterial culture and culture-independent
data
To isolate representative strains of major taxa, we also
performed bacterial culture on the infant faecal samples.
Bifidobacterium and Lactobacillus bacterial populations
in infant faeces were determined by plate counting
(Fig. 8). We observed a significant correlation between
the Bifidobacterium levels recorded by 16S analysis, and
the colony forming unit (CFU) counts (ρ = 0.24; p value =
6.64e−07). Likewise, Lactobacillus counts correlated with
16S-based data (ρ = 0.21; p value = 1.96e−05).
To determine whether significant differences in Bifido-
bacterium or Lactobacillus counts were present between
birth modes at a given time point, or between time
points for a given birth mode, we applied the Wilcoxon
rank sum test with Benjamini-Hochberg adjustment.
Due to the high level of variation recorded, we only ob-
served a trend for higher Bifidobacterium counts in FT-
SVD over FT-CS at week 1 (Fig. 8). Bifidobacterium
counts at week 1 were highest in FT-SVD (mean 7.45
log CFU/g) and lowest in PT-SVD infants (mean 2.57
log CFU/g). Bifidobacteria numbers increased across all
groups from week 1 to week 4, while at week 8, counts
were observed to stabilise. At week 24, numbers
remained stable across all groups. Similarly, Lactobacil-
lus was also most abundant in FT-SVD (mean 3.98 log
CFU/g) and lowest in PT-CS infants (mean 1.12 log
CFU/g) at week 1. Counts increased in all groups (ex-
cept PT-SVD) from week 1 to week 4; from week 4
to week 8 counts were stable in the PT-CS, FT-CS
and FT-SVD groups, while an increase was observed
in PT-SVD infants.
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Discussion
In this prospective study, we compared the gut micro-
biota of a cohort of initially breastfed infants from a sin-
gle geographical area (Cork, Ireland) who were born
under different conditions; SVD or CS delivery modes,
either FT or PT, in parallel with clinical data to 2 years.
Here, we present the data obtained in the first 24 weeks
of life. Our results consolidate and corroborate recent
findings surrounding the importance of birth mode on
the initial development of the microbiota [6, 33–35],
with robust data ensured by the large number of sub-
jects. The infants were sampled at four time points
across the first 24 weeks of life to enable longitudinal
analysis of the development of the nascent gut micro-
biota and were breastfed for a minimum of 4 weeks to
ensure there was a standard initial feeding regime. We
found a significant effect of PT-CS birth on infant
microbiota compared to FT infants, most likely due to a
number of challenges unique to PT infants, including
feeding type, antibiotic exposure (maternal and infant),
increased duration of hospital stay, gut immaturity and
immune immaturity. Low numbers of PT-SVD infants
were recruited as very few infants fitting to our defin-
ition of PT (<35 weeks gestation or <1500 g) were born
via SVD delivery mode in the hospital where the study
was based. Although it would be interesting to observe if
Fig. 7 Shannon diversity of different groups of infant gut microbiota increases with age, demonstrated by separating subjects by both age and
by birth mode. Significant differences between birth modes at a given time point were tested with a linear mixed effects model which adjusts
for potential batch effect (sequencing run), and the age of the infants at the given time point. Comparing different time points for a given birth
mode was performed with linear mixed effects models that adjust for the batch and the subjects
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PT infants not subjected to the environmental and anti-
biotic exposures detailed above still had an atypical micro-
biota profile in early life, such a prospective study would
be very difficult to perform because these medical inter-
ventions are clinically necessary for PT infant health. The
current study accurately represents the results of typical
conditions encountered by PT infants in developed coun-
tries. It should be noted that by week 24, there are no dif-
ferences in alpha diversity between any of the groups. This
may indicate that the microbiota has recovered from the
stresses associated with birth mode to a large extent by
6 months of age. Alternatively, the view could be
expressed that this is a crucial developmental window for
the establishment of lifelong host health.
The urine-derived metabolome was shown by co-
inertia analysis to mirror separations observed in the
faecal microbiota data at 4 weeks of age. This strongly
suggests that the microbiota of the infants is modulating
the metabolites produced. The specific metabolites driv-
ing the separation between FT and PT infants were di-
verse in nature, with the PT-CS gut in particular having
a large amount of altered metabolites. These results are
in good agreement with the study of Hyde et al. [36]
who studied birth mode in piglets, wherein CS piglets
were found to have lower concentration of succinic acid,
and higher concentration of glutamic acid than SVD pig-
lets. They also collate with Dessi et al. [37], which exam-
ined urine of infants by nuclear magnetic resonance. In
this study, the most important discriminating com-
pounds were associated with tyrosine, proline and argin-
ine metabolism, as well as with biosynthesis of
tryptophan, tyrosine, phenylalanine and the urea cycle.
At the systems level, regulation of tryptophan, tyrosine
and phenylalanine pathways plays a role in gut-brain sig-
nalling. A microbial influence on the profile of metabo-
lites within these pathways is suspected to contribute to
diverse psychiatric and behavioural disorders including
autism, schizophrenia and depression [38–40].
Bile acid derivatives are also present in greater amounts
in the PT infant urine metabolome, which may be indica-
tive of either jaundice or differential action of the micro-
biota in the gut of the infant. Strandvik et al. [41] found
tetrahydroxylated atypical bile acids were predominant in
PT newborns. Bile acids are main by-product of choles-
terol metabolism in the liver, and play a major role in
maintaining bile flow. Many enzymes are involved in the
conversion of cholesterol into bile acids; thus, improper
functioning of one of them can result in formation of
atypical bile acids, and probable liver dysfunction [42]. It
is not known for how long a time after birth this differ-
ence persists, thus the significance and physiologic effects
require further investigation.
The occurrence of dicarboxylic fatty acids suggests the
expression of alternative fatty acid oxidation mecha-
nisms. Considering the presence of phenylacetylglycine
among biomarkers, which is associated with disorders of
Fig. 8 Count data showing the absolute levels of Bifidobacterium and Lactobacillus at all time points from 1 to 24 weeks of age for all four infant
groups. Culture techniques were used to generate count data to verify the accuracy of the culture-independent sequencing data. Over 7000
strains of Bifidobacterium and Lactobacillus stocks were isolated and stocked in a biobank
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mitochondrial fatty acid beta-oxidation, we can suggest
that in PT infants, lipid metabolism was affected. This
was also suggested by the aforementioned study by Hyde
et al., where CS piglets accumulated more hepatic lipid
than their SVD counterparts. A series of liver free fatty
acids were also found to be up-regulated in CS piglets.
Phthalates are associated with hospital stays [43], PVC
flooring [44] and formula feeding and are more abundant
in the PT metabolome. Paracetamol derivatives were also
at higher levels in the PT gut, and are found in commonly
used medical products, such as Calpol®. Carnitine is asso-
ciated with red meat and has been controversially sug-
gested as being linked to increased risk for cardiovascular
disease [45]; levels of carnitine were found to be elevated
in the PT gut. However, vitamin D and vitamin E were
also more abundant in the PT metabolome, demonstrat-
ing that not all metabolites observed as elevated in the PT
urine are traditionally viewed as unfavourable metabolites.
This alteration of the gut environment as a neonate is
clearly a potential mode for progression of the conditions
which are associated with PT birth. More work is needed
to establish if the microbiota is a causative agent of this al-
tered metabolomic profile, and if modulation of the infant
gut microbiota would restore the metabolomic profile of a
PT infant to that of a FT infant.
There was a strong temporal separation of the infant
gut microbiota, showing close grouping together by age,
particularly for the samples at week 1 and week 24
(Fig. 3). The infants were divided into three separate
clusters based on differential abundance of certain taxa.
A large number of genera were absent at early time
points and then present at a relatively high level by
24 weeks of age, forming a distinct cluster. This cluster
contained genera that are core in adult enterotypes, such
as Prevotella, Blautia and Ruminococcus. This observa-
tion of the emergence of enterotype-like groupings of in-
fants provides a strong foundation to suggest that a
lifelong microbiota signature may be imprinted upon
infants as early as at six months of age. Alpha diver-
sity, as measured by the Shannon Diversity Index, in-
creased (or remained at the same level) with age
across all groups except from week 4 to week 8 in
FT-SVD infants. We were unable to attribute this
anomaly to any particular factor, and it remains an
interesting outlier in the dataset.
We observed an initially high proportion of Actinobac-
teria (almost exclusively Bifidobacterium) in FT-SVD,
Firmicutes in FT-CS and Proteobacteria in PT infants at
1 week of age. The observed differences in microbiota
composition were most pronounced at this early age.
The diversity of the PT gut microbiota at this time is
low, which may be due to maternal and neonatal anti-
biotic treatment. At genus level, Bacteroides were found
to be significantly less abundant at both 1 and 4 weeks
of age in FT-CS infants compared to FT-SVD infants
(both p < 0.001); Parabacteroides are also significantly
reduced in the FT-CS infants compared to FT-SVD at
4 weeks of age (p < 0.001). This indicates that Bacteroi-
detes may play a major role alongside Bifidobacterium in
the early infant gut microbiota, especially as certain spe-
cies of Bacteroides can metabolise human milk oligosac-
charides [46].
At 4 weeks of age, a trend was observed whereby these
breastfed FT-CS infants’ gut microbiota gradually devel-
oped to one more closely resembling that of FT-SVD in-
fants. At 8 weeks of age, the FT-CS microbiota
continued to become more similar to that of FT-SVD in-
fants, while PT infant community microbiota profile
remained more distinct. We noted that twins had a sig-
nificantly more similar microbiota composition than two
unrelated infants, which was anticipated. At this age,
twins have recently shared the same womb, birth mode
(typically CS), and large portion of their genetic makeup,
in addition to breastfeeding and environment. Therefore,
the microbiota of these individuals would be expected to
be more similar and it would be interesting to observe
how long this similarity lasts as the infants’ age. In a re-
cent study by our group, investigating the gut microbiota
composition in dichorionic triplets, we observed that
host genetics initially appeared to play a significant role
in the composition of the individual gut microbiota, but
by 12 months environmental factors were the major de-
terminant [47].
Although the microbiota of FT-CS and PT infants is
similar at genus level at 24 weeks of age, it remains dis-
tinct at OTU level. The differences in the gut microbiota
during this critical developmental period of an infant’s
life may have a long lasting effect on the immune system
or intestinal barrier function [48–51]. It is also known
that the microbiota has an influence on the metabolic
capabilities of an individual [52, 53]. This would place
CS, particularly for PT infants, firmly into a high risk
category for a number of developmentally associated dis-
orders and diseases. Early-life perturbations of the devel-
oping infant gut microbiota have also recently been
shown to impact on the central nervous system via the
gut-brain axis and may potentially lead to adverse men-
tal health outcomes later in life [54].
We observed a significant effect of breastfeeding on
the microbiota of the FT-CS infants but not on that of
the FT-SVD infants. Infants born by CS lack the natural
inoculum of bacteria obtained during passage through
the birth canal received by SVD infants. Instead, they are
exposed to environmental bacteria initially rather than
vaginal bacteria. These results show that FT-CS infants
may benefit from breastfeeding by obtaining some of the
bacteria that they are initially lacking because of birth
mode. SVD infants, contrastingly, have a “natural”
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microbiota profile that is not as obviously further devel-
oped by exposure to breast milk, at least in terms of al-
terations at genus level. Bifidobacterium levels have
previously been shown to be promoted by breast feeding
[12, 55] but though present at a high level in the infants
in our cohort, it was not one of the genera which in-
creased in abundance in breast fed infants (Additional
file 1: Table S8). It is very likely that the high proportion
of breast feeding in the first month of life of the infants
in this cohort has lessened or masked to some extent
the impact of sustained breastfeeding, particularly in
terms of maintaining the initial bacterial profile estab-
lished in FT-SVD infants.
Had post-conceptional age played an important role in
shaping the gut microbiota of infants, we would have ex-
pected their microbiota to be more similar at their due
dates, where all should theoretically be the same post-
conceptional age, and different at week 1, when they
were at different post-conceptional ages. However this
was not observed. We found that the infants’ microbiota
composition were more similar at week 1, when they
were all the same age after birth, and were different at
their due dates, when they would have different “post-
birth” ages at this point. This shows that age since birth
is more important than post-conceptional age, but that
neither exerts a large influence on shaping the compos-
ition of the PT neonatal microbiota.
We also noted that although certain bacteria, such as
Haemophilus, have a low relative proportion of the over-
all microbiota (average relative abundance = 1.4%), they
have a very high prevalence (75% of all infants) in the
INFANTMET cohort. This suggests they are occupying
a small, specific niche or carrying out a specific function
as part of the functioning ecosystem of the developing
gut. We also observed Bifidobacterium involved in a
number of negative correlations with other genera,
which is unsurprising as it becomes a more dominant
component of the FT-CS, PT-CS and PT-SVD gut
microbiota over time. This shows the competitive advan-
tage that Bifidobacterium has in the environment of the
infant gut as it displaces other bacteria.
Further novelty was added to this study through the use
of culture-dependent analysis in conjunction with culture-
independent sequencing. Culture-dependent techniques
remain valuable for their ability to isolate bacterial species
for further analysis. We focussed on populations of two
bacterial groups, Bifidobacterium spp. and Lactobacillus
spp., as these are known natural inhabitants of the healthy
infant intestinal microbiota, and there is substantial evi-
dence demonstrating the role of these bacteria as po-
tential probiotics [56–58]. Indeed, a bank of over 7000
putative Bifidobacterium and Lactobacillus strains de-
rived from infant faecal samples from INFANTMET is
currently being screened for probiotic potential.
Substantial inter-individual variation was observed for
Bifidobacterium and Lactobacillus counts which sup-
ports findings from other studies of infant intestinal
microbiota [59, 60].
More research is needed to establish whether one fac-
tor, or a combination of antibiotic treatment, gestation
length, C-section birth, or formula feeding regime are
causally associated with autoimmune and metabolic dis-
eases. However, the evidence from this study and the
current literature certainly suggests that factors which
disturb the establishment of the neonatal microbiota
should be avoided or minimised as much as possible. Fu-
ture studies may focus upon best methods for restor-
ation of the natural composition of the neonatal gut
following perturbation by any of the aforementioned fac-
tors. While probiotics are one avenue with some poten-
tial, the effects will likely be strain specific. Combination
studies, in conjunction with dosage testing, will need to
be tightly regulated in any prospective intervention.
Conclusions
The data indicate that mode of delivery and gestational
age at birth are the strong influencers of early gut micro-
biota structure following birth, with the impact of mode
of delivery and gestational age still apparent 24 weeks
after birth, although diminished with age. Currently, lit-
tle is known in literature about the overall metabolic sta-
tus of term and preterm neonates, and only a limited
number of metabolites are routinely measured in their
biological fluids by conventional methods. Co-inertia ana-
lysis of (urine) metabolomic and (gut) microbiota data in-
dicate that they correlate with one another, showing a
functional influence of the altered microbiota on several
metabolic pathways of PT-CS infants in particular.
Infants separated temporally by differentially abundant
taxa. The PT gut has a number of unique initial chal-
lenges at birth resulting in a distinct initial composition
at 1 week of age, high in Proteobacteria (p < 0.001).
There was very little development of the FT-SVD micro-
biota composition throughout the first 24 week of life,
with FT-SVD infants retaining a relative stable micro-
biota composition over this period, while FT-CS infants
develop a similar composition to FT-SVD after 8 weeks
of age. Of particular note was the prevalence of Actino-
bacteria and Bacteroidetes in FT-SVD infants very early
in life but that the FT-CS and PT infant gut microbiota
“catch up” in the first 24 weeks. Bifidobacterium was
found to be a major component of the infant gut, but not
significantly impacted by duration of breast feeding. Pro-
longed breastfeeding (>4 months) was found to impact the
gut microbiota of FT-CS infants but not FT-SVD infants.
Bacteroides were significantly more abundant in FT-
SVD infants compared to FT-CS infants over the first
month of life indicating an important role, perhaps
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similar to the importance currently attributed to Bifido-
bacterium in the early development of the infant gut
microbiota.
Taken together, these data highlight the importance of
breastfeeding particularly for infants born via Caesarean
delivery mode and the data provide new opportunities
for optimisation of IMF composition, with appropriate
new bioactive ingredients such as milk fractions, probio-
tics and prebiotics to effectively programme the early in-
fant gut microbiota in a manner closer to mother’s milk.
Best practice currently would appear to confirm the
adage that ‘breast is best’, and all current evidence ap-
pears to validate that statement for the maintenance of a
healthy neonatal gut microbiota, and this is particularly
true for infants delivered by CS birth mode.
Additional files
Additional file 1: Table S1. Metadata collected from the Infantmet
cohort. Blank space in the metadata table indicates that information on
that particular factor was not received for that infant (or mother). Table S2.
Preterm infant details and clinical metadata, including gestational age and
antibiotic exposure(s). Table S3. Complete list of all oligonucleotides used
for PCR amplification. Table S4. The influence of birth mode and getational
age on the infant gut microbiota from week 1 to 24 of life. Results of
pairwise PerMANOVA tests on Spearman distance matrix between birth
modes at given time points, after adjustment for batch effects. p value
adjustment was performed using Benjamini-Hochberg. Table S5. Reporting
classes of metabolites annotated in urine. Table S6. 2S MS2 and MS3 spec-
tra of annotated biomarkers. Detailed breakdown of the classification of the
biomarkers used for metabolomics analysis. Table S7. Prolonged breast-
feeding influences FT-CS but not FT-SVD infants’ gut microbiota. PerMA-
NOVA p value results comparing the microbiota of infants breastfed for
different durations, after adjusting for potential batch effect. Where birth
modes were combined, p values were obtained after adjusting for birth
modes. Table S8. Genera found to be significantly different at week 24 be-
tween infants that were breastfed for less than, or greater than 4 months. In
red (positive log2 fold change) indicates genera that are higher in infants
that were breastfed for longer, whereas in green are genera that are lower
in infants that were breastfed for longer. Table S9. Pairwise comparisons of
Spearman distances between groups of infants at due dates, grouped by
the number of weeks early that they were born. PerMANOVA was used on
Spearman distance matrix between all samples of the group pairs being
tested, and multiple testing. Table S10. Genera found to be differentially
abundant, or trending toward significance, between birth modes at week 1.
L2FC: Log2 fold change; p.adj: adjusted p value; sig.: significance level. Posi-
tive L2FC (in blue) indicates that the genus is higher in the first birth mode
of the pair listed, whereas a negative p value (in orange) indicates that the
genus is lower in the first birth mode listed. Table S11. Genera found to be
differentially abundant, or trending toward significance, between birth
modes at week 4. L2FC: Log2 fold change; p.adj: adjusted p value; sig.: sig-
nificance level. Positive L2FC (in blue) indicates that the genus is higher in
the first birth mode of the pair listed, whereas a negative p value (in orange)
indicates that the genus is lower in the first birth mode listed. Table S12.
Genera found to be differentially abundant, or trending toward significance,
between birth modes at week 8. L2FC: Log2 fold change; p.adj: adjusted p
value; sig.: significance level. Positive L2FC (in blue) indicates that the genus
is higher in the first birth mode of the pair listed, whereas a negative p value
(in orange) indicates that the genus is lower in the first birth mode listed.
Table S13. Genera found to be differentially abundant, or trending toward
significance, between birth modes at week 24. L2FC: Log2 fold change;
p.adj: adjusted p value; sig.: significance level. Positive L2FC (in blue) indi-
cates that the genus is higher in the first birth mode of the pair listed,
whereas a negative p value (in orange) indicates that the genus is lower in
the first birth mode listed. Table S14. Genera found to be differentially
abundant, or trending toward significance, between time points for FT-CS.
L2FC: Log2 fold change; p.adj: adjusted p value; sig.: significance level. Posi-
tive L2FC (in blue) indicates that the genus is higher at the earlier of the
two compared time points, whereas a negative p value (in orange)
indicates that the genus is lower in the first of the two time points.
Table S15. Genera found to be differentially abundant, or trending
toward significance, between time points for PT-CS. L2FC: Log2 fold
change; p.adj: adjusted p value; sig.: significance level. Positive L2FC
(in blue) indicates that the genus is higher at the earlier of the two
compared time points, whereas a negative p value (in orange) indicates that
the genus is lower in the first of the two time points. Table S16. Genera
found to be differentially abundant, or trending toward significance, be-
tween time points for FT-SVD. L2FC: Log2 fold change; p.adj: adjusted p
value; sig.: significance level. Positive L2FC (in blue) indicates that the genus
is higher at the earlier of the two compared time points, whereas a negative
p value (in orange) indicates that the genus is lower in the first of the two
time points. Table S17. Genera found to be significantly different, or trend-
ing toward different, between time points for PT-SVD. L2FC: Log2 fold
change; p.adj: adjusted p value; sig.: significance level. Positive L2FC (in blue)
indicates that the genus is higher at the earlier of the two compared time
points, whereas a negative p value (in orange) indicates that the genus is
lower in the first of the two time points. Table S18. Significant nega-
tive correlations of abundances of genera pairs. Correlations were
tested with Pearson correlation. The false discovery rate was adjusted
for with Benjamini-Hochberg adjustment. (XLSX 188 kb)
Additional file 2: Supplementary Materials and Methods. (DOC 39 kb)
Additional file 3: Figure S1. A selection of specific metabolites driving
the split in the co-inertia analysis that separates FT and PT gut by their
metabolomic profile. Each metabolite is represented by one or more fea-
tures. The metabolites on the left hand side are higher in PT infants and
the metabolites on the right hand side are higher in FT infants. (PDF
21785 kb)
Additional file 4: Figure S2. Twins have more similar microbiota to
one another than an unrelated infant at 1, 4, 8, and 24 weeks of age.
Using t tests with Monte-Carlo permutations, the Spearman distance be-
tween twins’ microbiota was determined and compared to unrelated in-
fants’ microbiota (***p < 0.001). (PDF 138 kb)
Additional file 5: Figure S3. Assessing the magnitude of change of
Shannon diversity between time points for subjects of a given birth
mode. Statistical models were used to determine if infants of one birth
mode changed more or less than infants of other birth modes at
different stages. Grey asterisks highlight significant differences from linear
mixed effects models that adjust for batch effect and the number of days
between time points for each subject. Black asterisks highlight significant
differences as determined by linear mixed effects models, adjusting for
batch effect, the number of days between time points, and the age of
infants at the first time point. (TIF 638 kb)
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